Pharmafile Logo
Pharmafocus logo
Advanced Search

Efficiency drive has saved NHS millions, say ministers

October 11, 2007

New targets set for PCTs have saved the NHS millions, according to new figures released by the Department of Health.Health …

News

Eucreas a step nearer European approval

October 11, 2007
Sales and Marketing

Novartis' new combination drug, Eucreas, is set for approval following recommendation from Europe's medicines regulator. Eucreas is a single-tablet combination …

News

Wyeth names new chief executive

October 10, 2007
Sales and Marketing Pfizer, Wyeth

Wyeth will begin 2008 with a new leader at the helm. Bernard Poussot will become the company's elected president and …

News

Gates Foundation invests $100m in unorthodox research

October 10, 2007
Research and Development

Scientists with novel ideas for research into some of the world's biggest diseases are to be offered a new source …

News

Latest news from Datamonitor

October 9, 2007
Research and Development

Critical Therapeutics starts Phase I trial of zileutonCritical Therapeutics has initiated a phase I clinical trial to assess the safety …

News

Wyeth buys Scottish biotech firm

October 8, 2007
Research and Development

Wyeth is to acquire Haptogen, a biotech research company based in Aberdeen which has a unique approach to targeting the …

News

GSK appoints Witty to top job

October 8, 2007
Sales and Marketing

GlaxoSmithKline has named JP Garnier's successor when he steps down as chief executive at the end of May next year.Andrew …

News

100m boost for NHS innovation

October 8, 2007

A new body has been set up to promote innovation across the NHS and pharmaceutical products will form a key …

News

Eisai to appeal against Alzheimer’s court ruling

October 3, 2007
Alzheimer's, Eisai, NICE

Eisai and Pfizer are to try once again to reverse NICE restrictions on Alzheimer’s drugs by appealing against the recent …

News

FDA rejects painkiller Prexige

October 3, 2007
Sales and Marketing reg, safety

Novartis has received a "not approvable" letter from the FDA for its painkiller Prexige because of concerns about potential liver …

News

Roche cuts Tarceva price while NICE deliberate

October 3, 2007

Roche has announced that it is to cut the price of its lung cancer treatment Tarceva for a limited time …

News

Latest news from Datamonitor

October 1, 2007
Research and Development

Cubicin approved for marketing in CanadaCubist Pharmaceuticals has said that Health Canada has approved Cubicin for marketing in Canada, where …

News

Finding top people for the top job

October 1, 2007
Business Services careers, management, recruitment

When it comes to filling the most senior roles in a company, whatever its size, executive search is, more often …

Feature

Leukaemia drug enters phase III studies in MS

September 28, 2007
Research and Development

Patients with multiple sclerosis could benefit from a drug currently used to treat leukaemia, with late-stage trials now commencing.Discovered by …

News

Society launches MS awareness campaign

September 28, 2007
Medical Communications

The MS Society has launched a campaign to raise awareness of multiple sclerosis and the help the patient group can …

News

Regulators and pharma to join forces on drug safety monitoring

September 28, 2007
Sales and Marketing reg, safety

Regulators, the pharma industry and academic institutions are to come together in a new global alliance to research drug side-effects. …

News

mXm launches event ROI Monitor

September 28, 2007
Medical Communications

mXm Medical Communications has launched a new tool to measure the return on investment from communications activities at medical meetings.Its …

News

BMA resists plans for London polyclinics

September 28, 2007

Recent government proposals to centralise London healthcare have met resistance among GPs. Independent trade union for doctors, the British Medical …

News

BMS makes $430m biotech acquisition

September 27, 2007
Research and Development

Bristol-Myers Squibb has significantly advanced its strategy to move into biologics with the acquisition of US biotech Adnexus.The $430 million …

News

News roundup from Datamonitor

September 26, 2007
Sales and Marketing

Alnylam and Merck end collaborationBiopharmaceutical company Alnylam Pharmaceuticals and Merck & Co. have mutually agreed to terminate their July 2006 …

News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026